How can we make ‘lazy’ artificial intelligence more transparent and relevant to the clinic?
Artificial intelligence (AI) is an important innovation in diagnostics, because it can quickly learn to recognize abnormalities that a doctor would also label as a disease. But the way that these systems work is often opaque, and doctors do have a better "overall picture" when they make the diagnosis. In a new publication, researchers from Radboudumc show how they can make the AI show how it’s working, as well as let it diagnose more like a doctor, thus making AI-systems more relevant to clinical practice.
Doctor vs AIIn recent years, artificial intelligence has been on the rise in the diagnosis of medical imaging. A doctor can look at an X-ray or biopsy to identify abnormalities, but this can increasingly also be done by an AI system by means of "deep learning" (see ’Background: what is deep learning’ below). Such a system learns to arrive at a diagnosis on its own, and in some cases it does this just as well or better than experienced doctors.
The two major differences compared to a human doctor are, first, that AI is often not transparent in how it’s analyzing the images, and, second, that these systems are quite "lazy". AI looks at what is needed for a particular diagnosis, and then stops. This means that a scan does not always identify all abnormalities, even if the diagnosis is correct. A doctor, especially when considering the treatment plan, looks at the big picture: what do I see? Which anomalies should be removed or treated during surgery?
AI more like the doctorTo make AI systems more attractive for the clinical practice, Cristina González Gonzalo, PhD candidate at the A-eye Research and Diagnostic Image Analysis Group of Radboudumc, developed a two-sided innovation for diagnostic AI. She did this based on eye scans, in which abnormalities of the retina occurred – specifically diabetic retinopathy and age-related macular degeneration. These abnormalities can be easily recognized by both a doctor and AI. But they are also abnormalities that often occur in groups. A classic AI would diagnose one or a few spots and stop the analysis. In the process developed by González Gonzalo however, the AI goes through the picture over and over again, learning to ignore the places it has already passed, thus discovering new ones. Moreover, the AI also shows which areas of the eye scan it deemed suspicious, therefore making the diagnostic process transparent.
An iterative processA basic AI could come up with a diagnosis based on one assessment of the eye scan, and thanks to the first contribution by González Gonzalo, it can show how it arrived at that diagnosis. This visual explanation shows that the system is indeed lazy – stopping the analysis after it as obtained just enough information to make a diagnosis. That’s why she also made the process iterative in an innovative way, forcing the AI to look harder and create more of a ‘complete picture’ that radiologists would have.
How did the system learn to look at the same eye scan with ‘fresh eyes’? The system ignored the familiar parts by digitally filling in the abnormalities already found using healthy tissue from around the abnormality. The results of all the assessment rounds are then added together and that produces the final diagnosis. In the study, this approach improved the sensitivity of the detection of diabetic retinopathy and age-related macular degeneration by 11.2+/-2.0% per image. What this project proves is that it’s possible to have an AI system assess images more like a doctor, as well as make transparent how it’s doing it. This might help these systems become easier to trust and thus to be adopted by radiologists.
Background: what is 'deep learning'?
Deep learning is a term used for systems that learn in a way that is similar to how our brain works. It consists of networks of electronic ‘neurons’, each of which learns to recognize one aspect of the desired image. It then follows the principles of ‘learning by doing’, and ‘practice makes perfect’. The system is fed more and more images that include relevant information saying – in this case – whether there is an anomaly in the retina, and if so, which disease it is. The system then learns to recognize which characteristics belong to those diseases, and the more pictures it sees, the better it can recognize those characteristics in undiagnosed images. We do something similar with small children: we repeatedly hold up an object, say an apple, in front of them and say that it is an apple. After some time, you don't have to say it anymore – even though each apple is slightly different. Another major advantage of these systems is that they complete their training much faster than humans and can work 24 hours a day.
Photo caption: This series shows the four different stages of the same eye scan described in this article. From left to right: the original image; with highlights of anomalies by human experts; with highlights of anomalies by one scan by an AI system; with highlights of anomalies made by an iterative series of scans by an AI system. Note that the iterative process yields a more complete overview of the anomalies present than the single assessment.
Related news items
Frank Walboomers 25-years work anniversary at Radboudumc17 September 2020
Frank Walboomers, associate professor at the research group Regenerative Biomaterials at the Dept. of Dentistry (theme Reconstructive & Regenerative Medicine), celebrated his 25th work anniversary at Radboudumc.read more
Tjitske Kleefstra appointed endowed professor of Clinical genetics and psychopathology of rare syndromes17 September 2020
Tjitske Kleefstra has been appointed endowed professor of Clinical genetics and psychopathology of rare syndromes at the department of Neurodevelopmental disorders, with effect from 1 September.read more
Annette Schenck appointed professor of Translational Genetics17 September 2020
Annette Schenck has been appointed professor of Translational Genetics at the department of Neurodevelopmental disorders, with effect from 1 August. The chair will bring together fundamental and translational research in the field of brain developmental disorders.read more
Transfer of new anti-hepatitis C drugs across the human placenta9 September 2020
In a recent publication in American Journal of Obstetrics and Gynecology, researchers from the Departments of Pharmacology and Toxicology, Pharmacy, Obstetrics and Gynecology, Gastroenterology and Hepatology, investigated the placental passage of two such drugs for the first time.read more
Nanda Rommelse appointed endowed professor of Neurodevelopmental disorders8 September 2020
Nanda Rommelse has been appointed professor of Neurodevelopmental disorders with effect from 1 September. The chair will function as a bridge between the Psychiatry Department of the Radboudumc with Karakter Child and Adolescent Psychiatry.read more
Does the COVID-19 cytokine storm exist? Research may have an impact on the chances of success of a specific treatment4 September 2020
Following the measurement of several important cytokines in patients with COVID-19 and various other severe diseases, researchers at Radboud university medical center now show that COVID-19 is not characterized by a cytokine storm.read more